HeXun Biosciences Co Ltd · TPEX:6986

HeXun Biosciences Co Ltd financial statements

HeXun Biosciences Co Ltd's income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in TWD

Income statement

LineFY2025FY2024FY2023FY2022FY2021
Revenue293.2M286.4M130.6M49.5M0
Cost of revenue26.9M25.7M16.8M4.86M0
Gross profit266.3M260.7M113.7M44.6M0
Research and development99.2M65.4M53.2M39.4M44.7M
Selling, general and administrative49.1M35.4M29.6M13.5M5.95M
Operating income118.0M155.7M27.4M-3.55M-50.7M
Depreciation and amortization28.9M24.7M20.3M14.7M11.9M
EBITDA146.9M180.4M47.7M11.2M-38.8M
Interest expense1.11M1.18M1.85M1.64M1.57M
Income before tax125.9M161.5M33.5M-5.19M-43.0M
Income tax14.2M
Net income111.9M147.2M33.5M-5.19M-43.0M
Earnings per share, basic2.433.200.89-0.14-1.41

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020
Cash and equivalents208.2M201.0M257.7M119.7M85.0M71.7M
Short-term investments301.4M172.0M72.0M72.0M
Receivables74.2M84.7M22.3M4.98M0
Inventory6.02M15.6M4.60M0
Current assets609.6M483.2M363.7M211.2M93.4M78.7M
Total assets837.1M706.9M571.4M404.2M294.6M266.2M
Accounts payable3.17M4.24M4.98M5.44M3.40M2.55M
Current liabilities62.5M53.8M30.2M20.0M7.83M11.8M
Long-term debt034.9M37.3M39.4M
Total debt35.0M70.1M69.4M74.1M80.9M
Total liabilities95.5M86.3M98.1M89.3M79.9M86.5M
Shareholders' equity741.6M620.6M473.4M314.9M214.8M179.7M
Shares outstanding46.0M46.0M37.5M37.5M30.5M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021
Cash from operations163.9M120.9M43.1M11.2M-35.5M
Capital spending-28.9M-37.3M-22.8M-1.23M0
Free cash flow135.0M83.6M20.3M10.0M-35.5M
Cash from investing-137.3M-25.3M-79.0M-26.9M
Cash from financing-40.3M120.1M102.5M75.8M
Change in cash7.21M-56.7M137.9M34.7M13.3M